Compile Data Set for Download or QSAR
Report error Found 95 Enz. Inhib. hit(s) with all data for entry = 6662
TargetTyrosine-protein kinase receptor(Human)
Astellas Pharma

US Patent
LigandPNGBDBM144297(US8969336, 388)
Affinity DataIC50: 0.170nMAssay Description:A recombinant retrovirus was created from expression plasmid FLAG-EML4-ALKv1/pMX-iresCD8 in which cDNA for EMLA-ALK fusion protein v1 was integrated,...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/22/2015
Entry Details
US Patent

TargetTyrosine-protein kinase receptor(Human)
Astellas Pharma

US Patent
LigandPNGBDBM144299(US8969336, 392)
Affinity DataIC50: 0.210nMAssay Description:A recombinant retrovirus was created from expression plasmid FLAG-EML4-ALKv1/pMX-iresCD8 in which cDNA for EMLA-ALK fusion protein v1 was integrated,...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/22/2015
Entry Details
US Patent

TargetTyrosine-protein kinase receptor(Human)
Astellas Pharma

US Patent
LigandPNGBDBM144298(US8969336, 391)
Affinity DataIC50: 0.220nMAssay Description:A recombinant retrovirus was created from expression plasmid FLAG-EML4-ALKv1/pMX-iresCD8 in which cDNA for EMLA-ALK fusion protein v1 was integrated,...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/22/2015
Entry Details
US Patent

TargetTyrosine-protein kinase receptor(Human)
Astellas Pharma

US Patent
LigandPNGBDBM144295(US8969336, 383)
Affinity DataIC50: 0.230nMAssay Description:A recombinant retrovirus was created from expression plasmid FLAG-EML4-ALKv1/pMX-iresCD8 in which cDNA for EMLA-ALK fusion protein v1 was integrated,...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/22/2015
Entry Details
US Patent

TargetProto-oncogene tyrosine-protein kinase ROS(Human)
Astellas Pharma

US Patent
LigandPNGBDBM144323(US8969336, 567)
Affinity DataIC50: 0.230nMAssay Description:A partial protein of only a kinase domain of ROS protein was purchased from Carna Biosciences Inc., Japan, and tests were conducted as in Test Exampl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/22/2015
Entry Details
US Patent

TargetTyrosine-protein kinase receptor(Human)
Astellas Pharma

US Patent
LigandPNGBDBM144293(US8969336, 377)
Affinity DataIC50: 0.240nMAssay Description:A recombinant retrovirus was created from expression plasmid FLAG-EML4-ALKv1/pMX-iresCD8 in which cDNA for EMLA-ALK fusion protein v1 was integrated,...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/22/2015
Entry Details
US Patent

TargetTyrosine-protein kinase receptor(Human)
Astellas Pharma

US Patent
LigandPNGBDBM144296(US8969336, 387)
Affinity DataIC50: 0.260nMAssay Description:A recombinant retrovirus was created from expression plasmid FLAG-EML4-ALKv1/pMX-iresCD8 in which cDNA for EMLA-ALK fusion protein v1 was integrated,...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/22/2015
Entry Details
US Patent

TargetTyrosine-protein kinase receptor(Human)
Astellas Pharma

US Patent
LigandPNGBDBM144294(US8969336, 378)
Affinity DataIC50: 0.260nMAssay Description:A recombinant retrovirus was created from expression plasmid FLAG-EML4-ALKv1/pMX-iresCD8 in which cDNA for EMLA-ALK fusion protein v1 was integrated,...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/22/2015
Entry Details
US Patent

TargetTyrosine-protein kinase receptor(Human)
Astellas Pharma

US Patent
LigandPNGBDBM144303(US8969336, 459)
Affinity DataIC50: 0.260nMAssay Description:A recombinant retrovirus was created from expression plasmid FLAG-EML4-ALKv1/pMX-iresCD8 in which cDNA for EMLA-ALK fusion protein v1 was integrated,...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/22/2015
Entry Details
US Patent

TargetProto-oncogene tyrosine-protein kinase ROS(Human)
Astellas Pharma

US Patent
LigandPNGBDBM144318(US8969336, 580 | US8969336, 553)
Affinity DataIC50: 0.290nMAssay Description:A partial protein of only a kinase domain of ROS protein was purchased from Carna Biosciences Inc., Japan, and tests were conducted as in Test Exampl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/22/2015
Entry Details
US Patent

TargetTyrosine-protein kinase receptor(Human)
Astellas Pharma

US Patent
LigandPNGBDBM144290(US8969336, 355)
Affinity DataIC50: 0.330nMAssay Description:A recombinant retrovirus was created from expression plasmid FLAG-EML4-ALKv1/pMX-iresCD8 in which cDNA for EMLA-ALK fusion protein v1 was integrated,...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/22/2015
Entry Details
US Patent

TargetReceptor-type tyrosine-protein kinase FLT3(Human)
Astellas Pharma

US Patent
LigandPNGBDBM144328(US8969336, 572)
Affinity DataIC50: 0.340nMAssay Description:A partial protein of only a kinase domain of FLT3 protein was purchased from Carna Biosciences Inc., Japan, and tests were conducted as in Test Examp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/22/2015
Entry Details
US Patent

TargetTyrosine-protein kinase receptor(Human)
Astellas Pharma

US Patent
LigandPNGBDBM144301(US8969336, 406)
Affinity DataIC50: 0.340nMAssay Description:A recombinant retrovirus was created from expression plasmid FLAG-EML4-ALKv1/pMX-iresCD8 in which cDNA for EMLA-ALK fusion protein v1 was integrated,...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/22/2015
Entry Details
US Patent

TargetReceptor-type tyrosine-protein kinase FLT3(Human)
Astellas Pharma

US Patent
LigandPNGBDBM144325(US8969336, 569)
Affinity DataIC50: 0.350nMAssay Description:A partial protein of only a kinase domain of FLT3 protein was purchased from Carna Biosciences Inc., Japan, and tests were conducted as in Test Examp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/22/2015
Entry Details
US Patent

TargetReceptor-type tyrosine-protein kinase FLT3(Human)
Astellas Pharma

US Patent
LigandPNGBDBM144317(US8969336, 579 | US8969336, 550)
Affinity DataIC50: 0.360nMAssay Description:A partial protein of only a kinase domain of FLT3 protein was purchased from Carna Biosciences Inc., Japan, and tests were conducted as in Test Examp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/22/2015
Entry Details
US Patent

TargetReceptor-type tyrosine-protein kinase FLT3(Human)
Astellas Pharma

US Patent
LigandPNGBDBM144309(US8969336, 574 | US8969336, 512)
Affinity DataIC50: 0.360nMAssay Description:A partial protein of only a kinase domain of FLT3 protein was purchased from Carna Biosciences Inc., Japan, and tests were conducted as in Test Examp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/22/2015
Entry Details
US Patent

TargetProto-oncogene tyrosine-protein kinase ROS(Human)
Astellas Pharma

US Patent
LigandPNGBDBM144328(US8969336, 572)
Affinity DataIC50: 0.370nMAssay Description:A partial protein of only a kinase domain of ROS protein was purchased from Carna Biosciences Inc., Japan, and tests were conducted as in Test Exampl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/22/2015
Entry Details
US Patent

TargetReceptor-type tyrosine-protein kinase FLT3(Human)
Astellas Pharma

US Patent
LigandPNGBDBM144320(US8969336, 582 | US8969336, 558)
Affinity DataIC50: 0.370nMAssay Description:A partial protein of only a kinase domain of FLT3 protein was purchased from Carna Biosciences Inc., Japan, and tests were conducted as in Test Examp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/22/2015
Entry Details
US Patent

TargetTyrosine-protein kinase receptor(Human)
Astellas Pharma

US Patent
LigandPNGBDBM144285(US8969336, 340)
Affinity DataIC50: 0.370nMAssay Description:A recombinant retrovirus was created from expression plasmid FLAG-EML4-ALKv1/pMX-iresCD8 in which cDNA for EMLA-ALK fusion protein v1 was integrated,...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/22/2015
Entry Details
US Patent

TargetReceptor-type tyrosine-protein kinase FLT3(Human)
Astellas Pharma

US Patent
LigandPNGBDBM144329(US8969336, 573)
Affinity DataIC50: 0.370nMAssay Description:A partial protein of only a kinase domain of FLT3 protein was purchased from Carna Biosciences Inc., Japan, and tests were conducted as in Test Examp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/22/2015
Entry Details
US Patent

TargetReceptor-type tyrosine-protein kinase FLT3(Human)
Astellas Pharma

US Patent
LigandPNGBDBM144327(US8969336, 571)
Affinity DataIC50: 0.390nMAssay Description:A partial protein of only a kinase domain of FLT3 protein was purchased from Carna Biosciences Inc., Japan, and tests were conducted as in Test Examp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/22/2015
Entry Details
US Patent

TargetProto-oncogene tyrosine-protein kinase ROS(Human)
Astellas Pharma

US Patent
LigandPNGBDBM144321(US8969336, 565)
Affinity DataIC50: 0.400nMAssay Description:A partial protein of only a kinase domain of ROS protein was purchased from Carna Biosciences Inc., Japan, and tests were conducted as in Test Exampl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/22/2015
Entry Details
US Patent

TargetProto-oncogene tyrosine-protein kinase ROS(Human)
Astellas Pharma

US Patent
LigandPNGBDBM144319(US8969336, 581 | US8969336, 554)
Affinity DataIC50: 0.410nMAssay Description:A partial protein of only a kinase domain of ROS protein was purchased from Carna Biosciences Inc., Japan, and tests were conducted as in Test Exampl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/22/2015
Entry Details
US Patent

TargetReceptor-type tyrosine-protein kinase FLT3(Human)
Astellas Pharma

US Patent
LigandPNGBDBM144315(US8969336, 577 | US8969336, 547 | Gilteritinib | U...)
Affinity DataIC50: 0.410nMAssay Description:A partial protein of only a kinase domain of FLT3 protein was purchased from Carna Biosciences Inc., Japan, and tests were conducted as in Test Examp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/22/2015
Entry Details
US Patent
PDB3D3D Structure (crystal)
TargetReceptor-type tyrosine-protein kinase FLT3(Human)
Astellas Pharma

US Patent
LigandPNGBDBM144321(US8969336, 565)
Affinity DataIC50: 0.440nMAssay Description:A partial protein of only a kinase domain of FLT3 protein was purchased from Carna Biosciences Inc., Japan, and tests were conducted as in Test Examp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/22/2015
Entry Details
US Patent

TargetReceptor-type tyrosine-protein kinase FLT3(Human)
Astellas Pharma

US Patent
LigandPNGBDBM144323(US8969336, 567)
Affinity DataIC50: 0.460nMAssay Description:A partial protein of only a kinase domain of FLT3 protein was purchased from Carna Biosciences Inc., Japan, and tests were conducted as in Test Examp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/22/2015
Entry Details
US Patent

TargetReceptor-type tyrosine-protein kinase FLT3(Human)
Astellas Pharma

US Patent
LigandPNGBDBM144318(US8969336, 580 | US8969336, 553)
Affinity DataIC50: 0.490nMAssay Description:A partial protein of only a kinase domain of FLT3 protein was purchased from Carna Biosciences Inc., Japan, and tests were conducted as in Test Examp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/22/2015
Entry Details
US Patent

TargetTyrosine-protein kinase receptor(Human)
Astellas Pharma

US Patent
LigandPNGBDBM144302(US8969336, 426)
Affinity DataIC50: 0.490nMAssay Description:A recombinant retrovirus was created from expression plasmid FLAG-EML4-ALKv1/pMX-iresCD8 in which cDNA for EMLA-ALK fusion protein v1 was integrated,...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/22/2015
Entry Details
US Patent

TargetReceptor-type tyrosine-protein kinase FLT3(Human)
Astellas Pharma

US Patent
LigandPNGBDBM144324(US8969336, 568)
Affinity DataIC50: 0.5nMAssay Description:A partial protein of only a kinase domain of FLT3 protein was purchased from Carna Biosciences Inc., Japan, and tests were conducted as in Test Examp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/22/2015
Entry Details
US Patent

TargetProto-oncogene tyrosine-protein kinase ROS(Human)
Astellas Pharma

US Patent
LigandPNGBDBM144326(US8969336, 570)
Affinity DataIC50: 0.510nMAssay Description:A partial protein of only a kinase domain of ROS protein was purchased from Carna Biosciences Inc., Japan, and tests were conducted as in Test Exampl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/22/2015
Entry Details
US Patent

TargetReceptor-type tyrosine-protein kinase FLT3(Human)
Astellas Pharma

US Patent
LigandPNGBDBM144322(US8969336, 566)
Affinity DataIC50: 0.510nMAssay Description:A partial protein of only a kinase domain of FLT3 protein was purchased from Carna Biosciences Inc., Japan, and tests were conducted as in Test Examp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/22/2015
Entry Details
US Patent

TargetProto-oncogene tyrosine-protein kinase ROS(Human)
Astellas Pharma

US Patent
LigandPNGBDBM144316(US8969336, 578 | US8969336, 549)
Affinity DataIC50: 0.510nMAssay Description:A partial protein of only a kinase domain of ROS protein was purchased from Carna Biosciences Inc., Japan, and tests were conducted as in Test Exampl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/22/2015
Entry Details
US Patent

TargetReceptor-type tyrosine-protein kinase FLT3(Human)
Astellas Pharma

US Patent
LigandPNGBDBM144314(US8969336, 576 | US8969336, 546)
Affinity DataIC50: 0.510nMAssay Description:A partial protein of only a kinase domain of FLT3 protein was purchased from Carna Biosciences Inc., Japan, and tests were conducted as in Test Examp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/22/2015
Entry Details
US Patent

TargetReceptor-type tyrosine-protein kinase FLT3(Human)
Astellas Pharma

US Patent
LigandPNGBDBM144319(US8969336, 581 | US8969336, 554)
Affinity DataIC50: 0.520nMAssay Description:A partial protein of only a kinase domain of FLT3 protein was purchased from Carna Biosciences Inc., Japan, and tests were conducted as in Test Examp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/22/2015
Entry Details
US Patent

TargetReceptor-type tyrosine-protein kinase FLT3(Human)
Astellas Pharma

US Patent
LigandPNGBDBM144316(US8969336, 578 | US8969336, 549)
Affinity DataIC50: 0.560nMAssay Description:A partial protein of only a kinase domain of FLT3 protein was purchased from Carna Biosciences Inc., Japan, and tests were conducted as in Test Examp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/22/2015
Entry Details
US Patent

TargetProto-oncogene tyrosine-protein kinase ROS(Human)
Astellas Pharma

US Patent
LigandPNGBDBM144317(US8969336, 579 | US8969336, 550)
Affinity DataIC50: 0.580nMAssay Description:A partial protein of only a kinase domain of ROS protein was purchased from Carna Biosciences Inc., Japan, and tests were conducted as in Test Exampl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/22/2015
Entry Details
US Patent

TargetProto-oncogene tyrosine-protein kinase ROS(Human)
Astellas Pharma

US Patent
LigandPNGBDBM144325(US8969336, 569)
Affinity DataIC50: 0.650nMAssay Description:A partial protein of only a kinase domain of ROS protein was purchased from Carna Biosciences Inc., Japan, and tests were conducted as in Test Exampl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/22/2015
Entry Details
US Patent

TargetTyrosine-protein kinase receptor(Human)
Astellas Pharma

US Patent
LigandPNGBDBM144292(US8969336, 370)
Affinity DataIC50: 0.650nMAssay Description:A recombinant retrovirus was created from expression plasmid FLAG-EML4-ALKv1/pMX-iresCD8 in which cDNA for EMLA-ALK fusion protein v1 was integrated,...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/22/2015
Entry Details
US Patent

TargetReceptor-type tyrosine-protein kinase FLT3(Human)
Astellas Pharma

US Patent
LigandPNGBDBM144326(US8969336, 570)
Affinity DataIC50: 0.660nMAssay Description:A partial protein of only a kinase domain of FLT3 protein was purchased from Carna Biosciences Inc., Japan, and tests were conducted as in Test Examp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/22/2015
Entry Details
US Patent

TargetReceptor-type tyrosine-protein kinase FLT3(Human)
Astellas Pharma

US Patent
LigandPNGBDBM144331(US8969336, 575)
Affinity DataIC50: 0.720nMAssay Description:A partial protein of only a kinase domain of FLT3 protein was purchased from Carna Biosciences Inc., Japan, and tests were conducted as in Test Examp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/22/2015
Entry Details
US Patent

TargetTyrosine-protein kinase receptor(Human)
Astellas Pharma

US Patent
LigandPNGBDBM144289(US8969336, 354)
Affinity DataIC50: 0.770nMAssay Description:A recombinant retrovirus was created from expression plasmid FLAG-EML4-ALKv1/pMX-iresCD8 in which cDNA for EMLA-ALK fusion protein v1 was integrated,...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/22/2015
Entry Details
US Patent

TargetProto-oncogene tyrosine-protein kinase ROS(Human)
Astellas Pharma

US Patent
LigandPNGBDBM144329(US8969336, 573)
Affinity DataIC50: 0.780nMAssay Description:A partial protein of only a kinase domain of ROS protein was purchased from Carna Biosciences Inc., Japan, and tests were conducted as in Test Exampl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/22/2015
Entry Details
US Patent

TargetProto-oncogene tyrosine-protein kinase ROS(Human)
Astellas Pharma

US Patent
LigandPNGBDBM144327(US8969336, 571)
Affinity DataIC50: 0.860nMAssay Description:A partial protein of only a kinase domain of ROS protein was purchased from Carna Biosciences Inc., Japan, and tests were conducted as in Test Exampl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/22/2015
Entry Details
US Patent

TargetProto-oncogene tyrosine-protein kinase ROS(Human)
Astellas Pharma

US Patent
LigandPNGBDBM144322(US8969336, 566)
Affinity DataIC50: 0.860nMAssay Description:A partial protein of only a kinase domain of ROS protein was purchased from Carna Biosciences Inc., Japan, and tests were conducted as in Test Exampl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/22/2015
Entry Details
US Patent

TargetTyrosine-protein kinase receptor(Human)
Astellas Pharma

US Patent
LigandPNGBDBM144304(US8969336, 466)
Affinity DataIC50: 0.930nMAssay Description:A recombinant retrovirus was created from expression plasmid FLAG-EML4-ALKv1/pMX-iresCD8 in which cDNA for EMLA-ALK fusion protein v1 was integrated,...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/22/2015
Entry Details
US Patent

TargetTyrosine-protein kinase receptor(Human)
Astellas Pharma

US Patent
LigandPNGBDBM144300(US8969336, 399)
Affinity DataIC50: 0.940nMAssay Description:A recombinant retrovirus was created from expression plasmid FLAG-EML4-ALKv1/pMX-iresCD8 in which cDNA for EMLA-ALK fusion protein v1 was integrated,...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/22/2015
Entry Details
US Patent

TargetProto-oncogene tyrosine-protein kinase receptor Ret(Human)
Astellas Pharma

US Patent
LigandPNGBDBM144322(US8969336, 566)
Affinity DataIC50: 0.950nMAssay Description:A partial protein of only a kinase domain of RET protein was purchased from Carna Biosciences Inc., Japan. The phosphorylation activity toward a pept...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/22/2015
Entry Details
US Patent

TargetTyrosine-protein kinase receptor(Human)
Astellas Pharma

US Patent
LigandPNGBDBM144281(US8969336, 110)
Affinity DataIC50: 0.990nMAssay Description:A recombinant retrovirus was created from expression plasmid FLAG-EML4-ALKv1/pMX-iresCD8 in which cDNA for EMLA-ALK fusion protein v1 was integrated,...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/22/2015
Entry Details
US Patent

TargetProto-oncogene tyrosine-protein kinase receptor Ret(Human)
Astellas Pharma

US Patent
LigandPNGBDBM144329(US8969336, 573)
Affinity DataIC50: 1nMAssay Description:A partial protein of only a kinase domain of RET protein was purchased from Carna Biosciences Inc., Japan. The phosphorylation activity toward a pept...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/22/2015
Entry Details
US Patent

TargetProto-oncogene tyrosine-protein kinase receptor Ret(Human)
Astellas Pharma

US Patent
LigandPNGBDBM144309(US8969336, 574 | US8969336, 512)
Affinity DataIC50: 1nMAssay Description:A partial protein of only a kinase domain of RET protein was purchased from Carna Biosciences Inc., Japan. The phosphorylation activity toward a pept...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/22/2015
Entry Details
US Patent

Displayed 1 to 50 (of 95 total ) | Next | Last >>
Jump to: